Companies: 10,795·Total market cap: $144.5T
Eagle Pharmaceuticals, Inc.

Eagle Pharmaceuticals, Inc.

EGRXOTCHealthcare● Active
$0.60
+$0.08(+14.29%)
Market Cap$7894531
P/E Ratio—
52W High$3.87
52W Low$0.085
Overview

Eagle Pharmaceuticals, Inc. (EGRX) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

EGRX · earnings · updated Jun 9, 2026

No earnings history available.

Next Earnings Date

Next earnings date not yet announced.
No earnings history available.
No analyst estimates available for EGRX.

About Earnings & Data Methodology

Data source: Financial Modeling Prep (FMP)  |  Updated: Hourly  |  Surprise%: (Actual − Estimate) / |Estimate| × 100  |  Fiscal year: EGRX ends December

Eagle Pharmaceuticals, Inc. (EGRX) reports earnings quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company.

Each quarter, investors track EGRX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. EGRX revenue tab →

Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
EGRX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
RevenuePrice historyFinancial statementsForecastDividendsMarket cap

Frequently asked questions

EGRX earnings · 3 questions

Eagle Pharmaceuticals, Inc.'s next earnings report is expected around TBD. EGRX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; EGRX historically reports after market close (AMC).

EGRX earnings datewhen is EGRX earningsEGRX next earnings datewhen does EGRX report earningsEGRX earnings calendar

▸ Source: FMP · Eagle Pharmaceuticals, Inc. SEC filings · US GAAP · Eagle Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026